$1.880
+0.051 (+2.73%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ERNA por análisis de gráficos similares
Alphio's ERNA stock price prediction model matches the current Ernexa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.90 (+0.93%). The 1-week path is $1.98 (+5.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Ernexa Therapeutics Inc?
Eterna Therapeutics Inc (ERNA) is not a good buy right now due to its poor financial performance and negative market trends. The stock has a current price of 1.88, which is a drastic drop of 93.52% year-to-date. Additionally, the RSI is at 36.6, indicating that the stock is nearing oversold territory, but this alone does not justify a buy given the lack of revenue and significant losses reported. The company has a forward P/E of 0, indicating no expected earnings growth, and a gross margin of 0% for the upcoming quarters, which raises concerns about its operational viability. The main risk is the ongoing net losses, with the most recent quarter showing a loss of 5.51 million, which could further erode investor confidence.
ERNA cerró en $1.88 el Friday, tras subir +2.73%
Ernexa Therapeutics Inc (ERNA) last closed at $1.88, gaining +2.73%. These facts feed the 1-day and 1-week ERNA price prediction above.
Factores de la previsión
Los factores de la previsión de Ernexa Therapeutics Inc (ERNA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ERNA, ordenadas por similitud.
Análisis de estacionalidad de ERNA
Historically the probability of a positive November return for ERNA is 0.00%. January offers the highest probability of a positive month at 57.38%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ERNA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $2.29 | $2.39 | $2.58 | +27.17% |
| Dec 2026 | $2.12 | $2.31 | $2.61 | +23.00% |
En 2026, se proyecta que Ernexa Therapeutics Inc (ERNA) oscile entre $2.12 y $2.61.
Previsión mensual de Ernexa Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Ernexa Therapeutics Inc promedie $2.39, con un mínimo de $2.29 y un máximo de $2.58.
En Dec de 2026, se proyecta que Ernexa Therapeutics Inc promedie $2.31, con un mínimo de $2.12 y un máximo de $2.61.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.